Business Wire

CA-VELODYNE-LIDAR,-INC.

18.8.2020 14:02:10 CEST | Business Wire | Press release

Share
Velodyne Lidar With Kaarta Cloud Can Produce Stunning 3D Maps

Velodyne Lidar, Inc. today announced Kaarta Cloud ® exclusively supports Velodyne’s lidar sensors. Kaarta’s new cloud-based application is a platform to process, store, and share 3D spaces. Paired with high quality lidar to capture the environment in 3D, the data is uploaded into Kaarta Cloud to quickly and easily process it into a point cloud for use. High quality 3D mobile mapping is now available to a broader consumer base.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200818005149/en/

Three Velodyne sensors – Ultra Puck™ , Puck™ and HDL-32E – are supported by Kaarta Cloud. After using a Velodyne sensor to scan the environment, Kaarta’s proprietary Kaarta Engine uses simultaneous localization and mapping (SLAM) algorithms to instantaneously process lidar data into a registered point cloud map. This enables users to produce accurate, measurable 3D models and vivid visual representations of complex environments, ranging from buildings and infrastructure to dangerous and hard-to-reach areas.

Mobile scanning systems are continually advancing and the possibilities for use are expansive. There is growing interest in lidar imaging for post-earthquake assessment, surveys of damaged buildings, aiding first responders in emergency situations and more. As the applications and sophistication of these tools grow, so does the size and complexity of the data collected, necessitating new ways of managing massive data sets that can be in excess of one billion points. To do so, Kaarta Cloud uses an ultra-high performance parallel-processed network to handle the processing of massive reality capture files. Kaarta Cloud workflow is designed to optimize operations, extract the maximum value from lidar scans, and facilitate data sharing and collaboration through its secure cloud storage platform.

Kaarta Cloud supports all of Kaarta’s robust mobile mapping systems which integrate Velodyne’s Puck, HDL-32E and Ultra Puck into Kaarta’s Stencil 2-16, Stencil 2-32 and Stencil Pro, respectively. Velodyne and Kaarta have strong experience in helping customers address mapping challenges in a wide variety of applications. For instance, Allvision and the City of Pittsburgh used a Velodyne-powered Kaarta solution to conduct detailed curb and parking analysis. This project provided information to help develop efficient and equitable urban mobility, enable quicker deliveries and significantly improve public parking experiences. Another example is McVeigh & Mangum Engineering , which used a Velodyne-powered Kaarta solution in a highly challenging initiative to document a North Carolina hospital with digital mapping.

Customers can now register for a 30-day free trial of the new Kaarta Cloud platform. Kaarta, as an Automated with Velodyne partner , will discuss how companies can use Velodyne’s lidar integration with Kaarta Cloud during a joint webinar on August 21 , from 10:00 to 10:45 a.m. PDT.

“Kaarta Cloud opens up access to Kaarta’s advanced SLAM-based technology to Velodyne’s lidar sensors, in addition to Kaarta systems,” said Kevin Dowling, CEO, Kaarta. “It provides a fast, flexible workflow to manage mobile mapping 3D data from field capture to finished data.”

“Kaarta Cloud is an exciting innovation for the growing ecosystem of software tools that allow Velodyne’s lidar customers and partners to produce awesome 3D digital twins,” said Jon Barad, Vice President of Business Development, Velodyne Lidar. “Online SLAM processing of lidar data expands the capabilities, scope, ease of use and speed at which the user community can leverage Velodyne’s sensors. This will help unlock the tremendous potential for lidar-based innovation and mapping applications.”

Velodyne Ultra Puck, Puck and HDL-32E sensors deliver a high resolution image to measure and analyze a variety of environments. They provide high quality resolution and performance along with a full 360-degree environmental view to deliver real-time 3D data.

About Velodyne Lidar

Velodyne provides smart, powerful lidar solutions for autonomy and driver assistance. Headquartered in San Jose, Calif., Velodyne is known worldwide for its portfolio of breakthrough lidar sensor technologies. Velodyne’s founder, David Hall, invented real-time surround view lidar systems in 2005 as part of Velodyne Acoustics. Mr. Hall’s invention revolutionized perception and autonomy for automotive, new mobility, mapping, robotics, and security. Velodyne’s high-performance product line includes a broad range of sensing solutions, including the cost-effective Puck™, the versatile Ultra Puck™, the autonomy-advancing Alpha Prime™, the ADAS-optimized Velarray™, and the groundbreaking software for driver assistance, Vella™.

About Kaarta

Kaarta, an innovator of real-time mobile 3D reality capture, transforms the real world into its digital twin with speed, fidelity and ease. Kaarta’s patent-pending technology, rooted in advanced robotics, is a fast track from capture to answer, streamlining workflow, reducing time, lowering cost and providing a new level of understanding of spaces for humans and autonomous machines alike. Now the spectrum of stakeholders across AECO, facilities planners and managers, natural resource management professionals and mobile robotics developers can work from the same framework. Additional information is available at www.kaarta.com .

Link:

ClickThru

Social Media:

https://www.facebook.com/velodyneLiDAR/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press release

- Vertex is on track for the U.S. FDA Prescription Drug User Fee Act (PDUFA) date of November 30 for potential accelerated approval of povetacicept –- Data published in NEJM and presented at ASN highlight povetacicept’s unique trifecta of efficacy, favorable safety, and the simplicity of dosing at-home every 4 weeks with a low-volume autoinjector –- Data presented at ASN include a qualitative study examining patient perspectives on current and emerging IgAN therapies, showing that 96% of participants preferred an autoinjector over a prefilled syringe, and 80% of participants preferred dosing every 4 weeks versus weekly dosing - - New clinical studies of povetacicept underway including a study evaluating patient experience on povetacicept administered via autoinjector - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Soc

BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press release

New data from HERIZON-GEA-01 Phase 3 trial show 36-month overall survival of nearly 40% with TEVIMBRA plus ZIIHERA and chemotherapy, and median OS reaching 27 monthsTEVIMBRA-containing arm was associated with a four-month longer median OS compared with ZIIHERA plus chemotherapy BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne,

Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:10:00 CEST | Press release

Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com

inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press release

Collaboration will establish the roadmap for bringing Pony.ai robotaxis to Kazakhstan on the inDrive ride-hailing platform, leveraging the NVIDIA Hyperion and the NVIDIA Halos safety system. inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a lea

Brenus Pharma's Novel In Vivo Immunotherapy STC-1010 Shows Safety, Activating T Cells in First-Line MSS Metastatic Colorectal Cancers With 2 Complete Responses.23.10.2026 14:50:00 CEST | Press release

Phase Ia BreAK CRC-001 at ESMO 2026: 43% of patients, all initially unresectable, became eligible for surgery Poster 1023P – Developmental Therapeutics Brenus Pharma, a clinical-stage biotech company, announced first data from the Phase Ia dose escalation of BreAK CRC-001. Nine unresectable patients were treated; 89% had liver metastases and 89% KRAS-mutant tumors, a population refractory to immunotherapy. Median follow-up: 8 months (1–14; data cut-off 6/08/2026). 95% of metastatic colorectal cancers are pMMR/MSS tumors, poorly immunogenic and resistant to immunotherapy. STC-1010, the company’s lead in vivo DC-engager, is designed to make these “cold” tumors visible to immune cells. Safety: no dose-limiting toxicity, only grade 1–2 related adverse events. Clinical activity (seven evaluable patients, RECIST 1.1): 100% disease control, 57% objective response rate (4/7). 43% of patients became operable (3/7): two with no evidence of disease afterward. Molecular profile: ctDNA dropped by u

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye